Viremic blood donor found by a rapid screening method in a season of high human parvovirus B19 activity in Niterói, Rio de Janeiro, Brazil

Memorias do Instituto Oswaldo Cruz

Volumn 99, Issue 1, 2004, Pages 95-99

  Setúbal, Sérgio ^a   Da Silva Cárdias, Cláudia Alessandra ^a   De Oliveira, Solange Artimos ^a   Do Nascimento, Jussara Pereira ^a,b  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^b Instituto de Technologia em Imunobiologicos   (Brazil)

Author keywords

Blood transfusion; Mass screening; Parvovirus B19, human; Transfusion transmitted virus

Indexed keywords

VIRUS ANTIBODY; VIRUS ANTIGEN;

ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CONTROLLED STUDY; ERYTHEMA INFECTIOSUM; FETUS DEATH; FETUS HYDROPS; HEMAGGLUTINATION; HEMOLYTIC ANEMIA; HUMAN; HYBRIDIZATION; IMMUNE DEFICIENCY; IMMUNODETECTION; MASS SCREENING; MICROBIAL ACTIVITY; MICROBIAL POPULATION DYNAMICS; NONHUMAN; PARVOVIRUS; POLYMERASE CHAIN REACTION; POPULATION; RISK ASSESSMENT; SECOND TRIMESTER PREGNANCY; SEROPREVALENCE; SPONTANEOUS ABORTION; VIREMIA; VIRUS IDENTIFICATION;

ERYTHROVIRUS; HYDROPS; PARVOVIRUS;

EID: 1642485783     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0074-02762004000100017     Document Type: Article

References (34)

1. Anderson MJ, Higgins PG, Davis LR, Willman JS, Jones SE, Kidd IM, Pattison JR, Tyrrell DAJ 1985. Experimental parvovirus infection in humans. J Infect Dis 152: 257-265.
2. Anderson MJ, Jones SE, Fisher-Hoch SP, Lewis E, Hall SM, Bartlett CLR, Cohen BJ, Mortimer PP, Pereira MS 1983. Human parovirus, the cause of erythema infectiosum (fifth disease)? Lancet 1: 1378.
3. Blümel J, Schmidt I, Effenberger W, Seiz H, Willkomnen H, Brackmann HH, Löwer J, Eis-Hübinger AM 2002. Parvovirus B19 transmission by heat-treated clotting factor concentrates. Transfusion 42: 1473-1481.
4. Brown KE 1997. Human parvovirus B19 epidemiology and clinical manifestations. In LJ Anderson, NS Young (eds), Human Parvovirus B19. Monographs in Virology, Vol. 20, Karger, Basel, p. 42-60.
5. Brown KE, Young NS 1997. Human parvovirus B19: pathogenesis of disease. In LJ Anderson, NS Young (eds), Human Parvovirus B19. Monographs in Virology, Vol. 20, Karger, Basel, p. 105-119.
6. Brown T, Anand A, Ritchie LD, Clewley JP, Reid TM 1984. Intrauterine parvovirus infection associated with hydrops fetalis. Lancet 2: 1033-1034.
7. Cohen BJ, Buckley MM 1988. The prevalence of antibodies to human parvovirus B19 in England and Wales. J Med Microbiol 25: 151-153.
8. Cohen BJ, Beard S, Knowles WA, Ellis JS, Joske D, Goldman JM, Hewitt P, Ward KN 1997. Chronic anemia due to parvovirus B19 infection in a bone marrow transplant patient after platelet transfusion. Transfusion 37: 947-952.
9. Cohen BJ, Field AM, Gudnadottir S, Beard S, Barbara JA 1990. Blood donor screening for parvovirus B19. J Virol Methods 30: 233-238.
10. Cohen B, Millar A, Schwind P 1995. Screening of blood donors for human parvovirus B19. Lancet 346: 1631.
11. Cruz AS, Serpa MJA, Barth OM, Nascimento JP 1989. Detection of the human parvovirus B19 in a blood donor plasma in Rio de Janeiro. Mem Inst Oswaldo Cruz 84: 279-280.
12. Freitas RB, Gusmäo SRB, Durigon EL, Linhares AC 1999. Survey of parvovirus B19 in a cohort of pregnant women in Belém, Brazil. Braz J Infect Dis 3: 6-14.
13. Freitas RB, Wong D, Boswell F, de Miranda MF, Linhares AC, Shirley J, Desselberger U 1990. Prevalence of human parvovirus (B19) and rubellavirus infections in urban and remote rural areas in northern Brazil. J Med Virol 32: 203-208.
14. Hayakawa F, Imada K, Towatari M, Saito H 2002. Life threatening human parvovirus B19 infection transmitted by intravenous immune globulin. British J Haematol 118: 1187-1189.
15. Hicks KE, Beard S, Cohen BJ, Clewley JP 1995. A simple and sensitive DNA hybridization assay used for the routine diagnosis of human parvovirus B19 infection. J Clin Microbiol 33: 2473-2475.
16. Hitzler WE, Runkel S 2002. Prevalence of human parvovirus B19 in blood donors as determined by a haemagglutination assay and verified by the polimerase chain reaction. Vox Sang 82: 18-23.
17. Kurtzman GJ, Ozawa K, Cohen B, Hanson G, Oseas R, Young NS 1987. Chronic bone marrow failure due to persistent B19 parvovirus infection. New Eng J Med 317: 287-294.
18. Laub R, Strengers P 2002. Parvovirus and blood products. Pathol Biol 50: 339-348.
19. Lisboa CP, Sáez-Alquézar A, Stewien KE, Chamone DF, Durigon EL 1996. Blood donors screening for parvovirus B19 using polymerase chain reaction. Programas e Resumos do VIII Encontro Nacional de Virologia da Sociedade Brasileira de Virologia, São Lourenço, p. 134.
20. McOmish F, Yap PL, Jordan A, Hart H, Cohen BJ, Simmonds P 1993. Detection of parvovirus B19 in donated blood: a model system for screening by polymerase chain reaction. J Clin Microbiol 31: 323-328.
21. Mori J, Field AJ, Clewley JP, Cohen BJ 1989. Dot blot hybridization assay of B19 virus DNA in clinical specimens. J Clin Microbiol 27: 459-464.
22. Nascimento JP, Buckley MM, Brown KE, Cohen BJ 1990. The prevalence of antibody to human parvovirus B19 in Rio de Janeiro, Brazil. Rev Inst Med Trop São Paulo 32: 41-45.
23. Nguyen QT, Sifer C, Schneider V, Allaume X, Servant A, Bernaudin F, Auguste V, Garbarg-Chenon A 1999. Novel human erythrovirus associated with transient aplastic anemia. J Clin Microbiol 37: 2483-2487.
24. Oliveira SA, Camacho LAB, Pereira ACM, Faillace TF, Setúbal S, Nascimento JP 2002. Clinical and epidemiological aspects of human parvovirus B19 infection in an urban area in Brazil (Niterói City Area, Rio de Janeiro state). Mem Inst Oswaldo Cruz 97: 965-970.
25. Pattison JR, Jones SE, Hodgson J, Davis LR, White JM, Stroud CE, Murtaza L 1981. Parvovirus infections and hypoplastic crisis in sickle-cell anaemia. Lancet 1: 664-665.
26. Pereira RFA, de Paula WNS, Cubel RCN, Nascimento JP 2001. Anti-VP1 and anti-VP2 antibodies detected by immunofluorescence assays in patients with acute human parvovirus B19 infection. Mem Inst Oswaldo Cruz 96: 507-513.
27. Rodis JF 1999. Parvovirus infection. Clin Obstet Gynecol 42: 07-120.
28. Sakata H, Ihara H, Sato S, Kato T, Ikeda H, Sekiguchi S 1999. Efficiency of donor screening for human parvovirus B19 by the receptor-mediated hemagglutinatyion assay method. Vox Sang 77: 197-203.
29. Santagostino E, Mannucci PM, Gringeri A, Azzi A, Morfini M 1994. Eliminating parvovirus B19 from blood products. Lancet 343: 798.
30. Sato Y, Takakura F, Kojima E, Fukada K, Okochi K, Maeda Y 1995. Screening of blood donors for human parvovirus B19. Lancet 346: 1237.
31. Schmidt I, Blumel J, Seitz H, Willkommen H, Löwer J 2001. Parvovirus B19 DNA in plasma pools and plasma derivatives. Vox Sang 81: 228-235.
32. Serjeant GR, Serjeant BE, Thomas PE, Anderson MJ, Patou G, Pattison JR 1993. Human parvovirus infection in homozygous sickle cell disease. Lancet 341: 1237-1240.
33. Weimer T, Streichert S, Watson C, Groner A 2001. High-titer screening PCR: a successful strategy for reducing the parvovirus B19 load in plasma pools for fractionation. Transfusion 41: 1500-1504.
34. Yoto Y, Kudoh T, Haseyama K, Suzuki N, Oda T, Katoh T, Takahashi T, Sekiguchi S, Chiba S 1995. Incidence of human parvovirus B19 DNA detection in blood donors. Br J Haematol 91: 1017-1018.